Banned Cough Syrup
- All
- News
- Videos
-
Banned Cough Syrup Worth Rs 3 Crore Seized In UP, 3 Arrested
A joint team of police and excise department officials seized banned cough syrup worth Rs 3 crore and arrested three accused in this connection here, an official said on Sunday.
-
For Every Bottle Of Killer Cough Syrup Doctor Prescribed, He Got Rs 2.5 As Cut
How would you price the life of a child? How would you assess its worth? For the doctor who prescribed the cough syrup to most of the 23 children who died after having it in Madhya Pradesh, the answer was simple: Rs 2.54.
-
'Not Of Standard Quality': Delhi Bans Sale Of 'Coldrif' Cough Syrup
The Delhi government has banned the sale, purchase and distribution of Coldrif cough syrup after it was declared "not of standard quality", an official order said.
-
Cough Syrup Linked To Child Deaths In India Not Shipped To US: Drug Regulator
The US Food and Drug Administration confirmed on Friday that toxic cough syrups linked to children's deaths in India had not been shipped to the United States.
-
Manipur Bans 2 Cough Syrup Brands Containing "Highly Toxic Chemical"
The Manipur government on Friday banned two brands of cough syrup found to contain a "highly toxic chemical".
-
Amid Cough Syrup Deaths, Auditor Flags Madhya Pradesh's Mega Purchase Of Banned Drugs
Even as Madhya Pradesh reels from the tragic deaths of 23 children in Chhindwara due to a toxic cough syrup, a new revelation from the Comptroller and Auditor General has exposed a deeper crisis in the state's drug regulation and procurement system.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
Drug Regulator's Advisory Over Lapses Amid Outrage Over Cough Syrup Deaths
India's top drug regulator has issued an advisory over serious lapses in pharmaceutical manufacturing practices, amid growing outrage over child deaths allegedly linked to contaminated cough syrups.
-
'Many Drug Companies Should Have Been Banned', Says Doctors' Group In Toxic Cough Syrup Case
Coldrif, now referred to as the "killer syrup," was recently examined by drug control authorities in Tamil Nadu. On October 2, the authorities declared that the samples were found to be adulterated, containing an alarming 48.6% weight/volume of DEG.
-
Exclusive: How Madhya Pradesh's Drug System Failed To Stop A 'Killer' Syrup
In Madhya Pradesh, 20 children are dead and seven more are battling for life after consuming a toxic cough syrup that should never have reached them.
-
Toxic Cough Syrup, Deadly Fallout: Here's How The Public Health Crisis Unfolded
What began with a few strange deaths linked to cough syrups rapidly snowballed into a multi-state public health and regulatory crisis. Here's how.
-
Exclusive: Coldrif Cough Syrup Contains Salt Banned 2 Years Ago For Children Under 4
Prescribed in children to treat symptoms of cold and cough, including runny nose, sneezing and sore throat and watery eyes, Coldrif contains Chlorpheniramine Maleate, Paracetamol and Phenylephrine.
-
Punjab Bans 'Coldrif' Cough Syrup Following Children Death In Other States
The Punjab government has banned the sale, distribution and use of Coldrif cough syrup in the wake of 14 children dying in Madhya Pradesh, reportedly due to the consumption of the contaminated medicine.
-
Karnataka Bans Cough, Cold Syrups For Children Under 2 Years
The Karnataka Health Department on Monday issued an advisory to healthcare institutions in the state not to prescribe or dispense cough and cold syrups to children below the age of two, following child deaths in Madhya Pradesh and Rajasthan.
-
Jharkhand Bans Cough Syrups Following Children Death In Other States
The Jharkhand government imposed an immediate ban on the sale and use of three cough syrups Coldrif, Respifresh, and Relife following reports of child deaths allegedly linked to the medicines in Madhya Pradesh and Rajasthan, officials said.
-
Banned Cough Syrup Worth Rs 3 Crore Seized In UP, 3 Arrested
A joint team of police and excise department officials seized banned cough syrup worth Rs 3 crore and arrested three accused in this connection here, an official said on Sunday.
-
For Every Bottle Of Killer Cough Syrup Doctor Prescribed, He Got Rs 2.5 As Cut
How would you price the life of a child? How would you assess its worth? For the doctor who prescribed the cough syrup to most of the 23 children who died after having it in Madhya Pradesh, the answer was simple: Rs 2.54.
-
'Not Of Standard Quality': Delhi Bans Sale Of 'Coldrif' Cough Syrup
The Delhi government has banned the sale, purchase and distribution of Coldrif cough syrup after it was declared "not of standard quality", an official order said.
-
Cough Syrup Linked To Child Deaths In India Not Shipped To US: Drug Regulator
The US Food and Drug Administration confirmed on Friday that toxic cough syrups linked to children's deaths in India had not been shipped to the United States.
-
Manipur Bans 2 Cough Syrup Brands Containing "Highly Toxic Chemical"
The Manipur government on Friday banned two brands of cough syrup found to contain a "highly toxic chemical".
-
Amid Cough Syrup Deaths, Auditor Flags Madhya Pradesh's Mega Purchase Of Banned Drugs
Even as Madhya Pradesh reels from the tragic deaths of 23 children in Chhindwara due to a toxic cough syrup, a new revelation from the Comptroller and Auditor General has exposed a deeper crisis in the state's drug regulation and procurement system.
-
364 Violations Found At Pharma Company Behind 'Killer' Cough Syrup: Sources
The pharmaceutical company, Sresan Pharma, at the centre of the cough syrup tragedy that has claimed over a dozen children's lives in Madhya Pradesh was found to be supplying the cough syrup without testing it, said a top source.
-
Drug Regulator's Advisory Over Lapses Amid Outrage Over Cough Syrup Deaths
India's top drug regulator has issued an advisory over serious lapses in pharmaceutical manufacturing practices, amid growing outrage over child deaths allegedly linked to contaminated cough syrups.
-
'Many Drug Companies Should Have Been Banned', Says Doctors' Group In Toxic Cough Syrup Case
Coldrif, now referred to as the "killer syrup," was recently examined by drug control authorities in Tamil Nadu. On October 2, the authorities declared that the samples were found to be adulterated, containing an alarming 48.6% weight/volume of DEG.
-
Exclusive: How Madhya Pradesh's Drug System Failed To Stop A 'Killer' Syrup
In Madhya Pradesh, 20 children are dead and seven more are battling for life after consuming a toxic cough syrup that should never have reached them.
-
Toxic Cough Syrup, Deadly Fallout: Here's How The Public Health Crisis Unfolded
What began with a few strange deaths linked to cough syrups rapidly snowballed into a multi-state public health and regulatory crisis. Here's how.
-
Exclusive: Coldrif Cough Syrup Contains Salt Banned 2 Years Ago For Children Under 4
Prescribed in children to treat symptoms of cold and cough, including runny nose, sneezing and sore throat and watery eyes, Coldrif contains Chlorpheniramine Maleate, Paracetamol and Phenylephrine.
-
Punjab Bans 'Coldrif' Cough Syrup Following Children Death In Other States
The Punjab government has banned the sale, distribution and use of Coldrif cough syrup in the wake of 14 children dying in Madhya Pradesh, reportedly due to the consumption of the contaminated medicine.
-
Karnataka Bans Cough, Cold Syrups For Children Under 2 Years
The Karnataka Health Department on Monday issued an advisory to healthcare institutions in the state not to prescribe or dispense cough and cold syrups to children below the age of two, following child deaths in Madhya Pradesh and Rajasthan.
-
Jharkhand Bans Cough Syrups Following Children Death In Other States
The Jharkhand government imposed an immediate ban on the sale and use of three cough syrups Coldrif, Respifresh, and Relife following reports of child deaths allegedly linked to the medicines in Madhya Pradesh and Rajasthan, officials said.
